De-SPAC Business Combination: LOI to Closing Mechanics

A de-SPAC transaction is the process by which a special purpose acquisition company completes the initial business combination it was formed to pursue. Unlike a conventional acquisition, the de-SPAC involves two sets of stockholders with different economic rights and interests (SPAC public stockholders with redemption rights and a trust-backed floor, and existing target company stockholders seeking liquidity or a public market for their shares), a parallel PIPE financing process, and an SEC disclosure and review process that approximates a second public offering for the combined entity. Managing these concurrent processes requires an understanding of the legal mechanics at each phase.

This sub-article is part of the SPAC and De-SPAC Transactions: Legal Guide. It covers the full de-SPAC business combination process in detail: target identification and exclusivity mechanics; the key terms of the letter of intent including valuation, PIPE contingency, minimum cash, and sponsor promote adjustments; definitive merger agreement structure and the choice between reverse triangular and direct merger forms; valuation methodologies used in de-SPAC transactions including discounted cash flow, trading multiples, and forward multiples; PIPE financing negotiation and disclosure; minimum cash condition mechanics; non-redemption agreements and redemption backstops; sponsor promote earn-back and forfeiture structures; interim covenants and material adverse change provisions; antitrust review under the Hart-Scott-Rodino Act and foreign investment review under CFIUS; regulatory approvals; shareholder and board approvals for both the SPAC and the target; closing conditions and the drop dead date; and extension mechanics and the redemption wave problem.

Acquisition Stars advises sponsors, target companies, and PIPE investors in de-SPAC transactions from LOI through closing. Nothing in this article constitutes legal advice for any specific transaction.

Target Identification and Exclusivity

The target identification process begins after the SPAC's IPO closes and the sponsor's management team begins actively evaluating potential business combination candidates. SPAC sponsors typically identify a target sector focus in the IPO prospectus (for example, technology-enabled services, healthcare, or industrial manufacturing) that is broad enough to preserve flexibility but specific enough to establish credibility with investors who evaluate the sponsor's sector expertise.

Initial outreach to potential targets is subject to SEC rules that restrict the SPAC from making specific communications about acquisition discussions before the parties have entered into a non-disclosure agreement. The SEC has clarified that written materials shared with a potential target that describe the SPAC's terms for a business combination may constitute a prospectus that must comply with Section 5 of the Securities Act unless an exemption applies. Most SPAC sponsors manage this risk by limiting initial outreach to oral discussions and entering into a mutual non-disclosure agreement before sharing any written materials describing deal terms or SPAC economics.

When a target has been identified and preliminary discussions have advanced to the point where both parties are prepared to proceed toward definitive documentation, the parties enter into an exclusivity agreement, which is typically memorialized either as a standalone agreement or as the binding portion of the letter of intent. Exclusivity periods in de-SPAC transactions typically run 45 to 90 days from the date of the letter of intent, with extension options exercisable by the SPAC if it has made defined progress toward definitive documentation by the initial expiration date. During the exclusivity period, the target is generally prohibited from soliciting or negotiating with other potential acquirors, and the SPAC is prohibited from pursuing other targets.

The valuation agreed to in the LOI is the most consequential economic term in the transaction because it determines the equity split at closing. If the pre-money enterprise value of the target is set at a level that implies a per-share value for the SPAC's Class A stock above the $10.00 trust value, public stockholders have an economic incentive to hold (rather than redeem) their shares. Conversely, if the implied per-share value is at or below trust value, the rational SPAC arbitrage investor will redeem rather than accept equity in the combined company at terms that offer no premium over cash.

Letter of Intent: Valuation, PIPE Contingency, and Promote Adjustments

The letter of intent in a de-SPAC transaction covers several categories of terms: economic terms including pre-money enterprise valuation and deal structure (merger vs. contribution); financing contingencies including the minimum PIPE commitment required before proceeding; protections for the SPAC and its stockholders including the minimum cash condition and representations about the target's business; and process terms including exclusivity, due diligence access rights, and the timeline to definitive documentation.

Pre-money enterprise valuation in a de-SPAC LOI is typically expressed as a multiple of the target's projected EBITDA or revenue for the forward year, and the LOI will specify whether the valuation is calculated on a cash-free, debt-free basis (with cash and debt adjusted at closing) or on a fully diluted basis including all options, warrants, and convertible instruments. The valuation methodology matters because the target's management may have strong views about which projections to use as the reference period (trailing twelve months vs. next twelve months vs. the next full fiscal year), and a difference in methodology can produce meaningfully different equity splits even when the nominal enterprise value is the same.

The PIPE contingency in the LOI specifies the minimum amount of PIPE commitments the sponsor must secure before the parties proceed to definitive documentation or before the LOI is considered binding on economic terms. Sponsors use the PIPE contingency as leverage to assess institutional investor interest in the transaction at the agreed valuation before committing to a full due diligence process and drafting cycle. If the PIPE market does not support the agreed valuation (because institutional investors believe the target is overvalued relative to comparable public companies), the sponsor must either renegotiate the valuation with the target or abandon the deal, and the PIPE contingency creates a contractual basis for that renegotiation.

Sponsor promote adjustments in the LOI are becoming a standard negotiating point as institutional investors and target companies have gained leverage in the de-SPAC market. A target that receives multiple SPAC approaches may condition its selection of a SPAC partner on the sponsor agreeing to accept a reduced promote or to place a portion of the founder shares in an earn-back structure tied to post-closing stock price performance. These negotiate-at-LOI promote adjustments are memorialized in the letter agreement amendments that are executed simultaneously with the definitive merger agreement, and they affect the disclosures required in the proxy statement regarding sponsor compensation in connection with the transaction.

Definitive Merger Agreement: Structure and Key Provisions

The definitive merger agreement in a de-SPAC transaction is the governing contract for the business combination and is typically executed simultaneously with the PIPE subscription agreements and the ancillary agreements (registration rights agreement, sponsor letter agreement amendment, employment agreements). The merger agreement is filed as an exhibit to the Form 8-K announcing the transaction and is publicly disclosed at the time of signing, triggering the proxy statement drafting and SEC review process.

The reverse triangular merger is the preferred structure in de-SPAC transactions involving U.S. targets because it allows the target to survive the merger as a wholly owned subsidiary of the SPAC, preserving the target's existing contracts, licenses, and regulatory authorizations without triggering the assignment or change-of-control provisions that would otherwise require third-party consents. In a reverse triangular merger, a newly formed, wholly owned merger subsidiary of the SPAC merges with and into the target (with the target as the surviving entity), and the target's stockholders receive the merger consideration in exchange for their target shares. The SPAC then changes its name to the combined company's name.

A direct merger (in which the target merges directly into the SPAC) is structurally simpler and avoids the step of forming a merger subsidiary but creates assignment risk for any target contract or license that prohibits assignment by operation of law. In a direct merger, the target ceases to exist and all of its assets and liabilities are assumed by the SPAC by operation of law. State licensing and regulatory authorizations, which are often non-transferable, may lapse or require reapplication in a direct merger, which is a significant risk for targets in regulated industries such as healthcare, financial services, or defense.

The representations and warranties in the de-SPAC merger agreement are negotiated on behalf of the target company (whose representations are the primary risk allocation mechanism for the SPAC) and the SPAC (whose representations confirm the SPAC's organization, capitalization, and trust account status). Target representations cover the standard scope: organization and authority, capitalization, financial statements, absence of undisclosed liabilities, material contracts, intellectual property, labor and employment, environmental compliance, compliance with law, and absence of litigation. The survival period and indemnification cap for target representations are negotiated consistent with the deal structure: if the transaction is structured as a stock deal (target stockholders receive SPAC shares), the indemnification mechanics are less important than in a cash deal because the recourse against individual selling stockholders is limited.

Valuation Methodologies: DCF, Trading Multiples, and Forward Multiples

De-SPAC transactions have historically been criticized for using aggressive valuation methodologies that produce higher enterprise values than conventional M&A or IPO valuation processes would support. The most significant structural feature enabling this criticism is that de-SPAC transactions may use financial projections prepared by the target's management and disclosed in the proxy statement, which is not permitted in a conventional IPO registration statement where the SEC limits forward-looking financial information to interim periods.

The primary valuation methodologies used in de-SPAC transactions are discounted cash flow analysis, comparable company trading multiples, and precedent transaction multiples. DCF analysis applies a discount rate to projected free cash flows over a five to ten-year period and a terminal value calculation, and is highly sensitive to assumptions about revenue growth, margin expansion, and the discount rate. In de-SPAC transactions involving high-growth companies with minimal current earnings, DCF analysis using management's projections can produce enterprise values that are many multiples of trailing revenue, justifying valuations that would not survive a comparable company analysis based on current metrics.

Comparable company trading multiples apply EV/EBITDA, EV/Revenue, or price-to-earnings ratios derived from the public trading prices of comparable companies to the target's projected financial metrics. The selection of comparable companies is a judgment-intensive process, and sponsors in de-SPAC transactions have sometimes selected peer groups that include the highest-valued companies in the target's sector rather than the most operationally similar ones, producing reference multiples that flatter the target's valuation. The SEC's 2022 proposed rules address the use of projections in de-SPAC proxy statements and would require more rigorous disclosure of the assumptions underlying management projections, which should improve the reliability of valuation support in future transactions.

Forward multiples, which apply comparable company multiples to the target's projected next-year or two-year-forward financial metrics rather than trailing metrics, are particularly common in de-SPAC transactions because many target companies are in high-growth phases where current metrics understate the near-term trajectory. A forward EV/Revenue multiple applied to the target's year-two projected revenue can produce an enterprise value substantially higher than a trailing multiple applied to current revenue, and the difference in the implied equity value can represent hundreds of millions of dollars in deal consideration for the target's existing stockholders. Counsel advising the SPAC board on the fairness of the transaction terms must evaluate whether forward multiples are being applied consistently with the multiples at which comparable companies in the sector actually trade on a forward basis.

PIPE Financing Negotiation and Disclosure

PIPE financing in de-SPAC transactions is arranged concurrently with the negotiation of the merger agreement and is typically closed simultaneously with the business combination. PIPE investors execute subscription agreements at the time the merger agreement is signed, committing to purchase a specified number of combined company shares at a fixed price per share (typically $10.00 per share) at the closing. The PIPE subscription agreements are material contracts that must be filed as exhibits to the merger agreement Form 8-K and described in the proxy statement.

The PIPE price is negotiated between the sponsor and the institutional investors based on the implied valuation of the combined company and the level of discount (if any) that investors require to commit capital in advance of the stockholder vote. In transactions where the combined company's implied valuation is attractive relative to comparable public companies, PIPE investors may commit at the full $10.00 per share price with no discount, reasoning that they are acquiring shares at trust value with upside participation in a business they view as undervalued at the agreed transaction terms. In transactions where the market appetite is weaker, PIPE investors may require a discount to $8.00 or $9.00 per share, or may require a price reset mechanism that adjusts the effective PIPE price downward if the combined company's stock trades below the subscription price for a specified period after closing.

PIPE registration rights are a standard component of PIPE subscription agreements. The combined company is obligated to file a resale registration statement covering the PIPE shares within a specified period after closing (typically 20 to 30 business days) and to use commercially reasonable efforts to have the registration statement declared effective within a specified number of days after filing (typically 60 to 90 days). If the registration statement is not effective within the specified period, PIPE investors may be entitled to liquidated damages (often expressed as a percentage of the subscription amount per month of delay) up to a specified cap. The registration rights and liquidated damages provisions create a meaningful post-closing obligation for the combined company's management and legal team.

Minimum Cash Condition and Non-Redemption Agreements

The minimum cash condition is a closing condition in favor of the target company that specifies the minimum amount of cash that must be available to the combined company at closing from the SPAC trust account (net of redemptions and the deferred underwriting discount) together with the PIPE proceeds. If the redemption level is too high and the available trust proceeds plus PIPE fall below the minimum cash threshold, the target company may elect to terminate the merger agreement (if the condition is a termination right rather than a waivable condition) or the parties must negotiate a waiver or additional capital commitment to bridge the gap.

Structuring the minimum cash condition requires the target to assess its actual post-closing capital needs: the amount of cash required to fund operations through the next twelve to eighteen months, any cash consideration owed to selling stockholders as part of the deal consideration, any debt that must be repaid at closing, and any transaction costs (legal, banking, accounting) that will be paid at closing from the combined company's cash. The minimum cash level must be high enough to ensure the combined company is adequately capitalized but low enough that it is achievable even in a higher-than-expected redemption scenario.

Non-redemption agreements are entered into by the sponsor with institutional investors who hold Class A shares and agree not to exercise their redemption right at the business combination vote. In exchange, the investor typically receives a transfer of a specified number of founder shares from the sponsor. The economic value of the founder share transfer to the investor is the mechanism by which the sponsor purchases the investor's commitment to remain in the SPAC rather than redeeming, and the cost to the sponsor is the dilution of the sponsor's own economic interest in the combined company. Non-redemption agreements must be disclosed in the proxy statement because they represent a material transaction between the sponsor and a SPAC stockholder that is relevant to the stockholder's assessment of the proposed business combination.

The disclosure of non-redemption agreements has become a focus of SEC enforcement. In 2023 the SEC charged multiple SPAC sponsors with failing to timely disclose non-redemption agreements that were entered into after the proxy statement was filed but before the stockholder vote, arguing that the agreements were material information that should have been disclosed in a proxy supplement. Sponsors who enter into non-redemption agreements at any point in the de-SPAC process should ensure that their disclosure counsel promptly reviews whether a proxy supplement is required.

Sponsor Promote Earn-Back Structures and Interim Covenants

Sponsor promote earn-back structures, negotiated at the time of the de-SPAC merger agreement, place a portion of the founder shares in escrow subject to forfeiture unless the combined company's stock reaches defined price thresholds within a specified period after closing. These structures have become standard in post-2021 de-SPAC transactions where institutional investors have demanded greater alignment between sponsor economics and post-combination performance before committing PIPE capital.

A typical earn-back structure places 20% to 50% of the sponsor's founder shares in an escrow account at the de-SPAC closing, subject to forfeiture unless specified vesting conditions are satisfied. The vesting conditions are typically tiered share price thresholds: for example, one-third of the escrowed shares vest if the stock trades above $12.00 for 20 consecutive trading days within three years of closing, one-third vest at $14.00, and one-third vest at $16.00. Shares that do not vest by the end of the earn-back period are cancelled. The escrowed shares remain outstanding during the earn-back period and are entitled to vote, which is a negotiating point for institutional investors who may object to the sponsor retaining voting power over shares that remain subject to forfeiture.

Interim covenants in the de-SPAC merger agreement govern the conduct of both the SPAC and the target during the period between signing and closing. Target covenants typically require the target to operate in the ordinary course of business consistent with past practice and prohibit it from taking actions outside the ordinary course without SPAC consent (including making acquisitions, incurring material indebtedness, entering into material contracts, paying dividends or making distributions, or materially changing its compensation practices). SPAC covenants typically prohibit the SPAC from amending its charter, waiving trust account conditions, taking actions that would cause the trust to fall below the per-share minimum, or entering into any other acquisition agreements during the exclusivity period.

Material adverse change (MAC) provisions define the circumstances under which the SPAC can terminate the merger agreement based on a deterioration in the target's business between signing and closing. De-SPAC MAC definitions typically follow the convention established in conventional M&A transactions: they define a MAC as a material adverse effect on the business, financial condition, assets, or results of operations of the target, subject to carve-outs for effects arising from general economic conditions, industry-wide developments, changes in law or regulation, acts of God, and changes in the market price of the SPAC's shares (though market-price changes are not themselves a MAC, they may be a symptom of a MAC if caused by a target-specific development). The COVID-19 pandemic forced significant litigation over MAC definitions in 2020, and the resolution of that litigation has informed the drafting of carve-outs in subsequent de-SPAC agreements.

Antitrust Review (HSR) and Foreign Investment Review (CFIUS)

De-SPAC transactions are subject to the Hart-Scott-Rodino Antitrust Improvements Act premerger notification requirements on the same basis as conventional M&A transactions. If the transaction meets the HSR size-of-transaction threshold (currently $119.5 million for the 2024 adjusted threshold) and the size-of-person thresholds, the parties must file HSR notifications with the Federal Trade Commission and the Department of Justice and observe a 30-day waiting period before closing. The SPAC is typically the acquiring person for HSR purposes, and its size is measured by the amount of voting securities and assets it would hold post-transaction, which for a SPAC with a significant trust account and a large target may exceed the relevant thresholds.

Early termination of the HSR waiting period, which the agencies historically granted routinely for transactions that raised no competitive concerns, was suspended by the FTC in 2021 and has been granted only selectively since. Sponsors and their counsel should assume a full 30-day waiting period and plan the closing timeline accordingly, building in additional time if the transaction involves a concentrated market or overlapping competitive businesses that might attract a second request for additional information (which extends the waiting period to a minimum of 30 days after substantial compliance).

CFIUS (the Committee on Foreign Investment in the United States) review applies to de-SPAC transactions in which a foreign person will acquire a U.S. business, or in which the combined company will engage in activities covered by CFIUS jurisdiction, including TID US businesses (technology, infrastructure, and data businesses subject to mandatory CFIUS filing requirements). SPACs with foreign co-sponsors or significant foreign PIPE investors may themselves trigger CFIUS jurisdiction if the transaction creates a covered foreign investment. The SPAC's counsel should analyze whether a CFIUS filing is required or advisable as part of the transaction planning process, because a failure to file when a mandatory filing is required can result in penalties and unwinding orders.

Regulatory Approvals and the Proxy Statement Process

In addition to HSR and CFIUS, de-SPAC transactions involving target companies in regulated industries may require approvals from sector-specific regulators including the FCC (for telecommunications businesses), state insurance commissioners (for insurance companies), the FDIC and state banking regulators (for financial institutions), and the FAA (for aviation businesses). These sector-specific approvals can take significantly longer than HSR review and must be identified early in the transaction planning process, because they may set the critical path to the closing timeline.

The proxy statement or Form S-4 registration statement for the de-SPAC transaction must be filed with the SEC and reviewed by the SEC staff before the SPAC can hold its stockholder vote. If the SPAC is issuing shares to the target's stockholders as merger consideration, the transaction must be registered under the Securities Act on Form S-4 (which combines the proxy statement with a registration statement). If the SPAC is paying cash consideration to the target's stockholders (funded by the trust account and PIPE), the transaction may be effected through a proxy statement on Schedule 14A without a concurrent registration statement.

The SEC comment letter process for a de-SPAC proxy statement or Form S-4 is more intensive than for a SPAC IPO because the transaction involves the full disclosure of the target company's business, financial statements, and management discussion that was not required in the IPO registration statement. The SEC staff typically issues one to two rounds of comments covering the target's financial statement compliance, the projections and valuation support, the PIPE terms and disclosure, the sponsor economics and conflicts of interest, and the risk factors for the combined company. The review process takes eight to fourteen weeks in most transactions, and sponsors should build this timeline into the merger agreement's outside date provisions.

Shareholder and Board Approvals: SPAC and Target

The SPAC's public stockholders must approve the business combination at a special meeting held after the proxy statement or Form S-4 is declared effective by the SEC. The approval standard is typically a majority of the outstanding shares entitled to vote, though some SPACs require a supermajority vote for business combination approval. The sponsor's Class B shares are entitled to vote on the business combination alongside the public Class A shares, and in transactions with high redemption rates, the sponsor's vote may be critical to achieving the required approval threshold.

SPAC boards are subject to fiduciary duties in approving de-SPAC transactions, and the SEC has emphasized that SPAC directors owe duties to all stockholders, including public stockholders with redemption rights, not merely to the sponsor who appointed them. The conflict of interest inherent in the sponsor's promote (which is earned only upon deal completion) means that a SPAC board recommending approval of a transaction is acting in circumstances where the sponsor's economic interests are not fully aligned with those of public stockholders who have a risk-free alternative through redemption. SPAC counsel should advise the board on its process obligations, including the use of special committees, independent financial advisors, and fairness opinions where appropriate.

Target company board approval is required under the applicable state corporate law (typically Delaware) as a precondition to the merger agreement's execution, and depending on the target's charter and the nature of the transaction, target stockholder approval may also be required. Private company targets typically obtain written consents from their stockholders in lieu of a formal meeting, using a majority-in-interest or supermajority approval threshold specified in the target's charter or stockholder agreements. If the target has a voting agreement among its major stockholders, that agreement may require or permit the major stockholders to execute a stockholder consent approving the merger, which is typically obtained simultaneously with the signing of the merger agreement to provide the SPAC with certainty that the target side of the approval is locked in.

Closing Conditions, Drop Dead Date, and Extension Mechanics

Closing conditions in a de-SPAC merger agreement include all of the standard conditions applicable to both parties (SEC effectiveness of the proxy statement or S-4, SPAC stockholder approval, target stockholder approval if required, HSR expiration or termination, absence of injunctions, bring-down of representations and warranties) as well as conditions specific to the de-SPAC structure (satisfaction of the minimum cash condition, execution of ancillary agreements, effectiveness of the warrant registration statement if required by the warrant agreement at closing).

The drop dead date is the outside date in the merger agreement after which either party may terminate the agreement if the closing has not occurred, provided the terminating party is not in material breach of the agreement. Drop dead dates in de-SPAC transactions are typically set 12 to 18 months from the signing date, with automatic extension provisions if the only outstanding closing condition at the drop dead date is a regulatory approval (HSR, CFIUS, or sector-specific approval) that has not yet been obtained. The relationship between the merger agreement's drop dead date and the SPAC's charter deadline to complete the business combination must be analyzed carefully: if the SPAC's charter deadline falls before the merger agreement's drop dead date, the SPAC will need to extend its charter deadline (through a stockholder vote and sponsor loan) to avoid a forced liquidation while the merger agreement is still in effect.

Extension mechanics in the SPAC charter permit the deadline for completing the business combination to be extended, typically in one-month or three-month increments, subject to a stockholder vote and the sponsor's deposit of additional funds into the trust account (typically $0.10 to $0.20 per outstanding Class A share per extension period). Each extension vote provides public stockholders with an additional redemption opportunity, and sponsors who rely on multiple extensions risk a cumulative redemption wave that progressively reduces the trust account below the minimum cash condition. Counsel managing the extension process must track the available extension periods under the charter, the per-share extension deposit requirements, and the remaining trust balance after each redemption cycle to assess whether the transaction remains financeable.

Redemption Waves, Transaction Failure, and Restructuring Options

Redemption waves occur when a large percentage of public stockholders elect to redeem their Class A shares at the business combination vote or at an extension vote, materially reducing the trust account balance available to fund the transaction. Redemption rates above 50% were rare in the 2019 to 2021 SPAC cycle but became common in 2022 and 2023 as rising interest rates increased the opportunity cost of holding SPAC shares at $10.00 and as the post-combination trading performance of many SPACs fell below the trust value, eroding investor confidence in the vehicle as a path to value creation.

When redemptions are expected to be high, sponsors have several structural options to bridge the funding gap. First, the PIPE can be upsized to replace anticipated redemption proceeds, provided institutional investors are willing to commit additional capital at acceptable terms. Second, the target can agree to lower the minimum cash condition, accepting a smaller cash infusion at closing in exchange for a higher equity allocation or other concessions. Third, the sponsor can enter into non-redemption agreements as described above, effectively paying a portion of the promote to retain public stockholders. Fourth, the combined company can arrange post-closing debt financing (a bridge loan or revolving credit facility) to supplement the reduced trust proceeds, provided a lender is willing to commit to the combined company in advance of the closing.

When none of these options is sufficient to bridge the funding gap, the parties face a choice between terminating the merger agreement and negotiating a restructured transaction. A renegotiated transaction at a lower valuation may satisfy the minimum cash condition at the reduced trust balance but requires the target's board to accept terms that may be materially less favorable than the original agreement. Termination and restart with a fresh search is the least attractive option for the sponsor (because it consumes time within the charter deadline and creates reputational risk) but may be preferable to closing a transaction at terms that are not in the long-term interest of the combined company or its stockholders. The decision requires careful judgment and a clear-eyed assessment of the alternatives, informed by counsel who understands both the transaction dynamics and the SPAC's remaining runway.

Frequently Asked Questions